FDA Issues Warning Letter to Miers Laboratories
November 12, 2025
November 12, 2025
WASHINGTON, Nov. 12 -- The U.S. Department of Health and Human Services Food and Drug Administration issued the following warning letter to Miers Laboratories Ltd from the Center for Drug Evaluation and Research:
* * *
Recipient: Mr. Andrew Criglington, Chief Executive Officer, Miers Laboratories, Ltd, 32 Waiu Street, Wainuiomata Lower Hutt, Wellington 5014, New Zealand, ac@mierslabs.co.nz
Issuing Office: Center for Drug Evaluation and Research (CDER), Unit . . .
* * *
Recipient: Mr. Andrew Criglington, Chief Executive Officer, Miers Laboratories, Ltd, 32 Waiu Street, Wainuiomata Lower Hutt, Wellington 5014, New Zealand, ac@mierslabs.co.nz
Issuing Office: Center for Drug Evaluation and Research (CDER), Unit . . .